What is the present valuation and projected CAGR of the metabolomics services market?
The metabolomics services market size has grown rapidly in recent years. It will grow from $2.65 $ billion in 2024 to $3.04 $ billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to increasing focus on biomarker discovery, increasing demand for advanced diagnostic tools, increasing utilization in agricultural research, increasing number of clinical trials, and rise in awareness of metabolomics applications.
The metabolomics services market size is expected to see rapid growth in the next few years. It will grow to $5.23 $ billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to growing prevalence of cancers, increasing demand for personalized medicine, increasing applications in life science and biotechnology, rising burden of diseases, and increasing development of healthcare infrastructure. Major trends in the forecast period include technological advancements, machine learning, bioinformatics tools, integration of artificial intelligence, and new diagnostic tools.
Get Your Free Sample of The Global Metabolomics Services Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19584&type=smp
What key drivers have fueled the metabolomics services market’s development over the years?
The increasing demand for personalized medicine is expected to propel the growth of the metabolomics services market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments for individual patients based on their genetic makeup, environmental factors, and lifestyle. The increasing demand for personalized medicine is driven by advancements in genomic technologies, enabling more precise and tailored treatments and a growing emphasis on individualized patient care for better outcomes. Metabolomics services enhance personalized medicine by providing detailed metabolic profiles that help tailor treatments to individual patients’ unique biochemical states, leading to more effective and targeted therapies. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, 12 new customized medications were approved in 2022, accounting for around 34% of all newly approved treatments, a significant increase over prior years. Therefore, increasing demand for personalized medicine drives the growth of metabolomics services.
What is the segmentation for the metabolomics services market?
The metabolomics servicesmarket covered in this report is segmented –
1) By Type: Untargeted Metabolomics Services, Targeted Metabolomics Services
2) By Product And Service: Metabolomics Bioinformatics Services, Chromatography, Mass Spectrometry, Other Product And Services
3) By End-User: Agriculture And Food, Biomedical And Pharmaceutical, Academic And Research Labs, Diagnostic Laboratories, Other End-users
Subsegments:
1) By Untargeted Metabolomics Services: Metabolite Profiling, Comprehensive Metabolomic Analysis, High-Throughput Metabolomics, Non-Targeted Mass Spectrometry Analysis, Data Mining and Interpretation Services
2) By Targeted Metabolomics Services: Quantitative Metabolite Analysis, Biomarker Discovery and Validation, Pathway Analysis, Specific Metabolite Measurement, Targeted Mass Spectrometry Services
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/metabolomics-services-global-market-report
Who are the most influential companies in the metabolomics services market?
Major companies operating in the metabolomics services market are BASF SE, Waters Corporation, Bruker Corporation, RTI International, SCIEX, BGI Group, Fred Hutchinson Cancer Research Center, OWL Inc., LECO Corporation, Metabolon Inc., MetaSysX Inc., Nightingale Health, Biocrates Life Sciences AG, Human Metabolome Technologies America Inc., CosmosID, Centre for Cellular and Molecular Platforms, Creative Proteomics, Cogentech, Stemina Biomarker Discovery Inc., Thermal Management Innovations Corporation, Afekta Technologies Ltd., MS-Omics, Clinical Microbiomics, DNA Xperts Private Limited, Metware Biotechnology Co. Ltd
What are the top industry trends projected to impact the metabolomics services market?
Major companies operating in the metabolomics services market are developing innovative diagnostic tools, to enhance disease detection and personalized medicine. Diagnostic tools are instruments and methods used to identify and assess medical conditions, diseases, or health issues, helping healthcare professionals make accurate diagnoses and guide treatment decisions. For instance, in October 2023, Sapient Bioanalytics LLC, a US-based biotechnology company, launched target metabolite and lipid panels for biomarker discovery and rapid time-to-insight. The panels offer a focused approach to identifying and quantifying specific metabolites and lipids, which enhances the precision of biomarker detection. These panels are designed for rapid time-to-insight, enabling quick turnaround of results, which is crucial for timely decision-making in research and clinical settings. These panels include advanced data analysis tools to interpret complex metabolic profiles and provide actionable insights.
What are the major regional insights for the metabolomics services market, and which region holds the top position?
North America was the largest region in the metabolomics services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Metabolomics Services Market Report 2025 Offer?
The metabolomics services market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Metabolomics services refer to the analytical and technological processes used to study the metabolites within a biological system. Metabolites are small molecules that are the end products of cellular processes, and their analysis provides a snapshot of the physiological state of an organism. It is used to study disease mechanisms, identify biomarkers, and improve drug development and personalized medicine.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19584
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
